Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

1.1K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.1K
Depression: Overview01:18

Depression: Overview

1.2K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.2K
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

2.0K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
2.0K
G-protein Coupled Receptors01:21

G-protein Coupled Receptors

133.8K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
133.8K
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

1.0K
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
1.0K
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

834
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
834

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Holistic soldier fitness: A concept for healthier tomorrow.

Medical journal, Armed Forces India·2023
Same author

<i>In situ</i> spatiotemporal characterization and analysis of chemical reactions using an ATR-integrated microfluidic reactor.

Lab on a chip·2023
Same author

S100PBP is regulated by mutated KRAS and plays a tumour suppressor role in pancreatic cancer.

Oncogene·2023
Same author

Transfusion support for a woman with <i>RHD*09.01.02</i> and the novel <i>RHD*01W.161</i> allele <i>in trans</i>.

Immunohematology·2022
Same author

First-episode psychosis: How long does it last? A review of evolution and trajectory.

Industrial psychiatry journal·2022
Same author

All, that was not bad in COVID crisis: Pearls of goodness from the furls of furnace.

Industrial psychiatry journal·2021
Same journal

Tuberculosis verrucosa cutis: An easy spotter yet frequently missed!

Medical journal, Armed Forces India·2026
Same journal

Non-Hodgkin lymphoma arising in a vallecular cyst: A rare clinical entity.

Medical journal, Armed Forces India·2026
Same journal

Utility of pre-operative magnetic resonance imaging (pelvis and abdomen) and combined tumour markers HE4 and CA125 in diagnosing early and advanced carcinoma endometrium.

Medical journal, Armed Forces India·2026
Same journal

Endoscopic management of Zenker's diverticulum.

Medical journal, Armed Forces India·2026
Same journal

Epithelial ingrowth post small incision lenticule extraction: CIRCLE software to the rescue.

Medical journal, Armed Forces India·2026
Same journal

Colistin rapid NP test for detection of colistin-resistance in colistin-resistant enterobacterales.

Medical journal, Armed Forces India·2026
See all related articles

Related Experiment Video

Updated: Mar 18, 2026

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
05:14

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

4.8K

Serum Serotonin Abnormality in Depression.

D Saldanha1, N Kumar2, Vssr Ryali3

  • 1Commandant, 92 Base Hosp C/o-56 APO.

Medical Journal, Armed Forces India
|July 14, 2016
PubMed
Summary
This summary is machine-generated.

Plasma serotonin levels in depressed patients improved after treatment with selective serotonin reuptake inhibitors (SSRIs). However, these serotonin changes did not significantly correlate with clinical improvements in depression or suicidal ideation scores.

Keywords:
DepressionSelective serotonin reuptake inhibitorsSerotonin

More Related Videos

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.6K
Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome
08:49

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome

Published on: September 23, 2015

9.3K

Related Experiment Videos

Last Updated: Mar 18, 2026

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
05:14

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

4.8K
Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.6K
Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome
08:49

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome

Published on: September 23, 2015

9.3K

Area of Science:

  • Neuroscience
  • Psychiatry
  • Biochemistry

Background:

  • Serotonin is a key neurotransmitter implicated in the pathophysiology and treatment of depression.
  • Understanding the relationship between serotonin levels and treatment response is crucial for managing depressive disorders.

Purpose of the Study:

  • To investigate the clinical correlates of plasma serotonin levels in patients with depression before and after treatment.
  • To examine the association between serotonin levels and depression/suicidal ideation severity.

Main Methods:

  • A study included 40 patients diagnosed with depression (ICD-10) and 40 healthy controls.
  • Beck's Depression Inventory (BDI) and Suicide Ideation Scale (SIS) were used for clinical assessments.
  • Plasma serotonin levels were measured before and after treatment with selective serotonin reuptake inhibitors (SSRIs).

Main Results:

  • Significant improvements were observed in BDI and SIS scores, as well as plasma serotonin levels, after SSRI treatment (p<.000).
  • No significant correlation was found between pre- and post-treatment serotonin levels and changes in rating scale scores (p > 0.05).
  • Patients with suicidal ideation exhibited lower baseline serotonin levels.

Conclusions:

  • Treatment with SSRIs significantly improved the clinical condition of depressed patients.
  • Despite clinical improvements, the changes in serum serotonin levels did not show a significant association with the observed therapeutic effects.